Prime Medicine Inc.

PRME | NASDAQ

Price Alert Chart Builder DCF Calculator

$3.19

+$0.07 (+2.24%)

At close: Sep 21, 2026, 4:00 PM ET

$3.22

+$0.03 (+0.94%)

After-hours: Sep 21, 2026, 7:56 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+2.24%

(1D)

Rating

Updated: Aug 12, 2026

11.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $576.17M

1D Range

3.10 3.27

52W Range

2.67 6.94

Valuation (TTM)

PE -2.90

PB 14.47

EV/EBITDA -3.29

Valuation (NTM)

Forward PE N/A

Forward PEG 0.59

Price Target $7.50

Cash Flow

FCF Yield -27.7%

SBC Adj. FCF Yield -32.4%

SBC Impact -16.8%

Margins

Gross Margin -1025.6%

Operating Margin -4824.9%

FCF Margin -3923.7%

Growth (CAGR)

Revenue 3Y | 5Y 54.3% | 68.1%

Dil EPS 3Y | 5Y 32.0% | 7.3%

FCF 3Y | 5Y 14.4% | -4.4%

Returns

ROA -75.5%

ROE -188.3%

ROIC -86.8%

Financial Health

Net Debt

$17.41M

Current Ratio 3.05

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Prime Medicine, Inc. operates as a biotechnology firm, dedicated to delivering genetic therapies for various diseases by strategically employing advanced gene editing technology. Central to their plat...

Sector Healthcare

Industry Biotechnology

Employees 146

IPO Date Oct 19, 2022

Website www.primemedicine.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 6, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$7.50

Upside

+135.11%

Buy (3)

Hold (1)

Sell (0)

Analyst Details ➞